Fund moves

Thermo Fisher Scientific (TMO): Baillie Gifford & Co reduced its stake -65K shares

Baillie Gifford & Co reduced its stake in Thermo Fisher Scientific, per its Q4 2024 13F.

539K
Shares reported · -65K vs prior quarter
0.22%
Disclosed portfolio weight
$280M
Reported value
Holdings as of
Dec 31, 2024
Filed
Jan 31, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 7, 2024InsiderDirector purchased ~$8.9K of TMO shares in the open market
  2. Dec 2, 2024Insider · 1 personInsiders: 7 sales (~$5.3M)
  3. Dec 3, 2024Insider · 1 personInsiders: 7 sales (~$5.3M)
  4. Dec 5, 2024FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.25-32 ug/mL
  5. Dec 9, 2024InsiderDirector purchased ~$2.1K of TMO shares in the open market
  6. Dec 19, 2024FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL
  7. Jan 8, 2025FDAFDA device clearance: Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel

What came next

  1. Feb 3, 2025InsiderCFO sold ~$5.83M of TMO shares in the open market
  2. Feb 4, 2025Insider · 2 peopleInsiders: 2 sales (~$5.9M)
  3. Feb 10, 2025FDAFDA device clearance: The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of…
  4. Feb 10, 2025FDAFDA device clearance: The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dilution range of…
  5. Feb 19, 2025InsiderDirector sold ~$8.4K of TMO shares in the open market
  6. Feb 24, 2025InsiderOfficer sold ~$9.73M of TMO shares in the open market
  7. Feb 25, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  8. Feb 27, 2025FDAFDA device clearance: The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL
  9. Mar 3, 2025InsiderOfficer sold ~$945K of TMO shares in the open market
  10. Mar 3, 2025Congress · 1 personMembers of Congress: 2 purchases
  11. Mar 4, 2025Insider · 1 personInsiders: 9 sales (~$5.2M)
  12. Mar 5, 2025Insider · 1 personInsiders: 8 sales (~$4.2M)
  13. Mar 10, 2025InsiderOfficer sold ~$2.01M of TMO shares in the open market
  14. Mar 27, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  15. Apr 7, 2025Congress · 2 peopleMembers of Congress: 2 sales
  16. Apr 8, 2025Congress · 2 peopleMembers of Congress: 2 sales
  17. Apr 11, 2025Congress · 2 peopleMembers of Congress: 2 sales
  18. Apr 15, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL
  19. Apr 21, 2025Congress · 1 personMembers of Congress: 2 sales
  20. Apr 28, 2025InsiderOfficer sold ~$129K of TMO shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

How this filing works

Explore the data

Common questions

What does this filing report about Thermo Fisher Scientific (TMO) stock?

Baillie Gifford & Co reduced its stake in Thermo Fisher Scientific, per its Q4 2024 13F. Now 539K shares, $280M reported value, 0.22% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2024. Filed: Jan 31, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Thermo Fisher Scientific recently?

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the TMO page.

Does this mean TMO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data